| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 397,249 | 387,853 | 342,119 | 413,883 | | Cost of Revenue | 335,241 | 328,047 | 290,926 | 358,336 | | | Gross Profit | 62,008 | 59,806 | 51,193 | 55,547 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,953 | 23,411 | 23,255 | 22,998 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 10,761 | 10,743 | 10,643 | 9,020 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,294 | 25,652 | 17,295 | 23,529 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,636 | (497) | 497 | (9) | | Earnings Before Interest And Taxes | 27,930 | 25,155 | 17,792 | 23,520 | | Interest Expense | 5,769 | 5,781 | 5,762 | 4,643 | | Income Before Tax | 22,161 | 19,374 | 12,030 | 18,877 | | Income Tax Expense | 517 | 383 | 101 | 328 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,644 | 18,991 | 11,929 | 18,549 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (392) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,644 | 18,991 | 11,929 | 18,157 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,644 | $18,991 | $11,929 | $18,157 |
|
0.50% Nasdaq 
Income Statement
